Camden, New Jersey Clinical Trials

A listing of Camden, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 96 clinical trials
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

blood test
covid-19
Temple Univ School of Med
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

Jefferson University Hospitals, Thomas Jefferson University
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

This will be a phase 1a randomized, open label, multi-center study with approximately 24 subjects. All subjects will receive standard of care (SOC) per institutional guidelines for treatment of hospitalized patients with COVID-19 infection. In addition to SOC, the brequinar group will receive 5 daily doses of brequinar 100 mg.

coronavirus infection
dyspnea
malaise
myalgia
pao2
Temple University
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
PCSK9i in AAA12

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
API Trial-T1

API Trial-T1

Test AP Sit1
 (4.6 away) Contact site
  • 0 views
  • 18 Sep, 2024
  • 1 location
PCSK9i in AAA123

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test2a
 (4.6 away) Contact site
  • 0 views
  • 20 Nov, 2024
  • 1 location
PCSK9i in AAA123  

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test2a
 (4.6 away)
  • 0 views
  • 18 Mar, 2025
  • +1 other locations
PCSK9i in AAA1234

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.6 away) Contact site
  • 0 views
  • 04 Mar, 2025
  • +1 other locations
PCSK9i in AAA1235

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.6 away) Contact site
  • 0 views
  • 04 Mar, 2025
  • +1 other locations
Phase I Study in Advanced Malignancies

RDT aims to take advantage of the relatively safer toxicity profiles of both lower dose radiation therapy and systemic ALA to treat non-superficial lesions in a manner similar to photodynamic therapy. The doses of radiation administered in this study will be lower than those typically used to treat cancer. However, …

photodynamic therapy
serum bilirubin
growth factor
red blood cell transfusion
serum total bilirubin level
Fox Chase Cancer Center
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location